In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Applied Therapeutics Inc (NASDAQ: APLT) closed the day trading at $0.51 down -1.63% from the previous closing price of $0.52. In other words, the price has decreased by -$1.63 from its previous closing price. On the day, 1.01 million shares were traded. APLT stock price reached its highest trading level at $0.5339 during the session, while it also had its lowest trading level at $0.5.
Ratios:
For a better understanding of APLT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 1.94. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.12.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’25 when Perfetti Riccardo sold 10,366 shares for $0.44 per share. The transaction valued at 4,561 led to the insider holds 890,409 shares of the business.
Funtleyder Leslie D. sold 14,502 shares of APLT for $6,381 on Mar 04 ’25. The insider now owns 390,459 shares after completing the transaction at $0.44 per share. On Mar 04 ’25, another insider, Chinoporos Constantine, who serves as the insider of the company, sold 447 shares for $0.44 each. As a result, the insider received 197 and left with 271,436 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 73676544 and an Enterprise Value of 45857604. For the stock, the TTM Price-to-Sale (P/S) ratio is 613.97 while its Price-to-Book (P/B) ratio in mrq is 4.16. Its current Enterprise Value per Revenue stands at 378.988 whereas that against EBITDA is -0.412.
Stock Price History:
The Beta on a monthly basis for APLT is 2.03, which has changed by -0.9123288 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 15.29%, while the 200-Day Moving Average is calculated to be -50.44%.
Shares Statistics:
Over the past 3-months, APLT traded about 1.57M shares per day on average, while over the past 10 days, APLT traded about 839800 shares per day. A total of 141.94M shares are outstanding, with a floating share count of 124.18M. Insiders hold about 13.77% of the company’s shares, while institutions hold 61.16% stake in the company. Shares short for APLT as of 1755216000 were 8783564 with a Short Ratio of 5.60, compared to 1752537600 on 13246500. Therefore, it implies a Short% of Shares Outstanding of 8783564 and a Short% of Float of 6.140000000000001.
Earnings Estimates
The dynamic stock of Applied Therapeutics Inc (APLT) is currently attracting attention from 3.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.09 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.45 and -$0.66 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is -$0.54, with 3.0 analysts recommending between -$0.32 and -$0.66.
